Kai_01
Nov 10, 11:32 AM
$KURA Some key facts to be aware of. Still early days in DD but so far looking extraordinary.
1. FDA approved, at ultra speed, which is often a good sign.
2. Undervalued (rNPV is
$9.40)
3. EV is small relative to its cash; extremely strong funding structure.
4. 88.96M outstanding shares (in case you were also in IOVA, for reference, IOVA has 400M!)
5. A one-day pill, no cell therapy and so on related complexity and challenges
6. Extraordinary commentary from doctors hinting at a potential high penetration rate and high-quality clinical trial design and data
7. Strong and full calendar catalyst (see image with black background attached). No binary event until 2028 (always peaceful, although of course there's potential for upside and downside)
8. Buy out setup; potentially by one of its partners (Kyowa Kirin)
9. CEO bought 100,000 shares for about
$1.24 million a few months ago
10. Price targets by analysts (never to use as a key investment variable but good nonetheless).
1 replies